1: Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy JY, Paesmans M, Isola J, Piccart MJ. Related Articles, Links
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
Clin Cancer Res. 2002 May;8(5):1107-16.
PMID: 12006526 [PubMed - indexed for MEDLINE]
2: Hirota H, Gosky D, Berger NA, Chatterjee S. Related Articles, Links
Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity.
Int J Oncol. 2002 Feb;20(2):311-8.
PMID: 11788894 [PubMed - indexed for MEDLINE]
3: Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K. Related Articles, Links
Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Anticancer Res. 2001 Jul-Aug;21(4A):2357-62.
PMID: 11724293 [PubMed - indexed for MEDLINE]
4: Di Leo A, Larsimont D, Gancberg D, Jarvinen T, Beauduin M, Vindevoghel A, Michel J, Focan CH, Ries F, Gobert PH, Closon-Dejardin MT, Dolci S, Rouas G, Paesmans M, Lobelle JP, Isola J, Piccart MJ. Related Articles, Links
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.
Ann Oncol. 2001 Aug;12(8):1081-9.
PMID: 11583189 [PubMed - indexed for MEDLINE]
5: Granzen B, Efferth T, Keller U, Beniers AJ, Mertens R, Jakse G, Fuzesi L. Related Articles, Links
Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Anticancer Res. 2001 Jan-Feb;21(1B):771-6.
PMID: 11299842 [PubMed - indexed for MEDLINE]
Time used: 31 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005